321 related articles for article (PubMed ID: 30449218)
1. NF-κB p65 Knock-down inhibits TF, PAI-1 and promotes activated protein C production in lipopolysaccharide-stimulated alveolar epithelial cells type II.
Liu B; Wu Y; Wang Y; Cheng Y; Yao L; Liu Y; Qian H; Yang H; Shen F
Exp Lung Res; 2018; 44(4-5):241-251. PubMed ID: 30449218
[TBL] [Abstract][Full Text] [Related]
2. SN50 attenuates alveolar hypercoagulation and fibrinolysis inhibition in acute respiratory distress syndrome mice through inhibiting NF-κB p65 translocation.
Wu Y; Wang Y; Liu B; Cheng Y; Qian H; Yang H; Li X; Yang G; Zheng X; Shen F
Respir Res; 2020 May; 21(1):130. PubMed ID: 32460750
[TBL] [Abstract][Full Text] [Related]
3. Triptolide dose-dependently improves LPS-induced alveolar hypercoagulation and fibrinolysis inhibition through NF-κB inactivation in ARDS mice.
Yang H; Qian H; Liu B; Wu Y; Cheng Y; Zheng X; Li X; Yang G; He T; Li S; Shen F
Biomed Pharmacother; 2021 Jul; 139():111569. PubMed ID: 34243622
[TBL] [Abstract][Full Text] [Related]
4. BAY11-7082 inhibits the expression of tissue factor and plasminogen activator inhibitor-1 in type-II alveolar epithelial cells following TNF-α stimulation via the NF-κB pathway.
Cheng Y; Liu B; Qian H; Yang H; Wang Y; Wu Y; Shen F
Exp Ther Med; 2021 Feb; 21(2):177. PubMed ID: 33552241
[TBL] [Abstract][Full Text] [Related]
5. IKKβ regulates the expression of coagulation and fibrinolysis factors through the NF-κB canonical pathway in LPS-stimulated alveolar epithelial cells type II.
Liu B; Wang Y; Wu Y; Cheng Y; Qian H; Yang H; Shen F
Exp Ther Med; 2019 Oct; 18(4):2859-2866. PubMed ID: 31572531
[TBL] [Abstract][Full Text] [Related]
6. Andrographolide Suppresses Expressions of Coagulation and Fibrinolytic Inhibition-Related Factors in LPS-Induced Alveolar Epithelial Cell Type II via NF-κB Signal Pathway In Vitro.
Yang G; Li X; Li Q; Xiao C; Qian H; Yang H; Shen F
Intensive Care Res; 2022; 2(3-4):61-70. PubMed ID: 36523372
[TBL] [Abstract][Full Text] [Related]
7. 6-Gingerol ameliorates alveolar hypercoagulation and fibrinolytic inhibition in LPS-provoked ARDS via RUNX1/NF-κB signaling pathway.
Li Q; Xiao C; Gu J; Chen X; Yuan J; Li S; Li W; Gao D; Li L; Liu Y; Shen F
Int Immunopharmacol; 2024 Feb; 128():111459. PubMed ID: 38181675
[TBL] [Abstract][Full Text] [Related]
8. Andrographolide sulfonate attenuates alveolar hypercoagulation and fibrinolytic inhibition partly via NF-κB pathway in LPS-induced acute respiratory distress syndrome in mice.
Qian H; Yang H; Li X; Yang G; Zheng X; He T; Li S; Liu B; Wu Y; Cheng Y; Shen F
Biomed Pharmacother; 2021 Nov; 143():112209. PubMed ID: 34649343
[TBL] [Abstract][Full Text] [Related]
9. [Berberine dose-dependently inhibits the expression of procoagulant and fibrinolytic inhibitory factors in lipopolysaccharide-induced rat type II alveolar epithelial cells].
Li X; Yang G; Shen F; Zheng X; He T; Li S; Cheng Y; Li Q; Li W; Qin J
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Jan; 33(1):53-58. PubMed ID: 33565401
[TBL] [Abstract][Full Text] [Related]
10. miR-9 targeting RUNX1 improves LPS-induced alveolar hypercoagulation and fibrinolysis inhibition through NF-κB inactivation in ARDS.
Xiao C; Li Q; Xiao J; Chen X; Yuan J; Li S; Li W; Gao D; Li L; Liu Y; Shen F
Int Immunopharmacol; 2023 Jul; 120():110318. PubMed ID: 37201407
[TBL] [Abstract][Full Text] [Related]
11. [Effects of andrographolide on the expression of procoagulant and fibrinolytic inhibition factors in rat type II alveolar epithelial cells stimulated by lipopolysaccharide].
Yang G; Li X; Shen F; Zheng X; He T; Li S; Cheng Y; Li Q; Li W; Qin J
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Feb; 33(2):155-160. PubMed ID: 33729132
[TBL] [Abstract][Full Text] [Related]
12. Emodin improves alveolar hypercoagulation and inhibits pulmonary inflammation in LPS-provoked ARDS in mice via NF-κB inactivation.
Liu B; Cheng Y; Wu Y; Zheng X; Li X; Yang G; He T; Li S; Shen F
Int Immunopharmacol; 2020 Nov; 88():107020. PubMed ID: 33182048
[TBL] [Abstract][Full Text] [Related]
13. Binding domain peptide ameliorates alveolar hypercoagulation and fibrinolytic inhibition in mice with lipopolysaccharide-induced acute respiratory distress syndrome Via NF-κB signaling pathway.
Wang Y; Wu Y; Liu B; Yang H; Qian H; Cheng Y; Li X; Yang G; Zheng X; Shen F
Am J Transl Res; 2022; 14(6):3854-3863. PubMed ID: 35836863
[TBL] [Abstract][Full Text] [Related]
14. Puerarin prevents vascular endothelial injury through suppression of NF-κB activation in LPS-challenged human umbilical vein endothelial cells.
Deng HF; Wang S; Li L; Zhou Q; Guo WB; Wang XL; Liu MD; Liu K; Xiao XZ
Biomed Pharmacother; 2018 Aug; 104():261-267. PubMed ID: 29775893
[TBL] [Abstract][Full Text] [Related]
15. Anisodamine counteracts lipopolysaccharide-induced tissue factor and plasminogen activator inhibitor-1 expression in human endothelial cells: contribution of the NF-kappa b pathway.
Ruan QR; Zhang WJ; Hufnagl P; Kaun C; Binder BR; Wojta J
J Vasc Res; 2001; 38(1):13-9. PubMed ID: 11173990
[TBL] [Abstract][Full Text] [Related]
16. Alpha-melanocyte-related tripeptide, Lys-d-Pro-Val, ameliorates endotoxin-induced nuclear factor kappaB translocation and activation: evidence for involvement of an interleukin-1beta193-195 receptor antagonism in the alveolar epithelium.
Haddad JJ; Lauterbach R; Saadé NE; Safieh-Garabedian B; Land SC
Biochem J; 2001 Apr; 355(Pt 1):29-38. PubMed ID: 11256945
[TBL] [Abstract][Full Text] [Related]
17. Perfluorocarbon attenuates lipopolysaccharide-mediated inflammatory responses of alveolar epithelial cells in vitro.
Xu SF; Wang P; Liu RJ; Zhao J; Zhang XN; Fu ZZ; Gao LM; Liang ZX; Sun JP; Chen LA
Chin Med J (Engl); 2011 Aug; 124(16):2534-9. PubMed ID: 21933601
[TBL] [Abstract][Full Text] [Related]
18. Immunopharmacological potential of selective phosphodiesterase inhibition. II. Evidence for the involvement of an inhibitory-kappaB/nuclear factor-kappaB-sensitive pathway in alveolar epithelial cells.
Haddad JJ; Land SC; Tarnow-Mordi WO; Zembala M; Kowalczyk D; Lauterbach R
J Pharmacol Exp Ther; 2002 Feb; 300(2):567-76. PubMed ID: 11805218
[TBL] [Abstract][Full Text] [Related]
19. [Effect of retroviral vector mediating RNA interference on the release of tumor necrosis factor-alpha in lipopolysaccharide-stimulating macrophage].
Wu CT; Zhu GF; Zhao JH; Zhang XF; Jin LY; Yan SF
Zhonghua Yi Xue Za Zhi; 2010 May; 90(18):1283-7. PubMed ID: 20646605
[TBL] [Abstract][Full Text] [Related]
20. RUNX1 targeting AKT3 promotes alveolar hypercoagulation and fibrinolytic inhibition in LPS induced ARDS.
Xiao C; Liu J; Cheng Y; Wu Y; Li Q; Chen X; Yuan J; Dong Q; Li L; Liu Y; Shen F
Respir Res; 2024 Jan; 25(1):54. PubMed ID: 38267920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
